Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|November 9, 2014
Intralesional therapy for metastatic melanomaSarah Sloot, Omar M Rashid, Jonathan S Zager
Expert Opinion on Drug Metabolism & Toxicology|September 2, 2014
Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusionOmar M Rashid, Sarah Sloot, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|March 25, 2016
Developments in Intralesional Therapy for Metastatic MelanomaSarah Sloot, Omar M Rashid, Arnod A Sarnaik, et al.
Expert Opinion on Pharmacotherapy|January 25, 2014
Long-term effects of BRAF inhibitors in melanoma treatment: friend or foe?Sarah Sloot, Inna V Fedorenko, Keiran S M Smalley, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 15, 2014
[Preoperative medical record-keeping can be improved: new informed consent form assists both physicians and patients]Wouter K G Leclercq, Sarah Sloot, Bram J Keulers, et al.
Patient Safety in Surgery|October 30, 2016
Challenging the knowledge base and skillset for providing surgical consent by orthopedic and plastic surgeons in the Netherlands: an identified area of improvement in patient safetyWouter K G Leclercq, Sarah Sloot, Bram J Keulers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 28, 2014
Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence studySarah Sloot, Jason Boland, John A Snowden, et al.
Journal of Neuro-Oncology|December 19, 2014
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastasesKamran A Ahmed, Jessica M Freilich, Sarah Sloot, et al.
Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Melanoma Research|January 6, 2016
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategySarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, et al.
Pageof 2